CVT-1: Began Phase II trial in 200 people who will be given an American Heart Association-recommended diet for six to eight weeks to stabilize their cholesterol

By WIR Staff | Feb 13, 1995 | 8:00 AM GMT

CV Therapeutics, Palo Alto
Product: CVT-1, a

Read the full 70 word article

How to gain access

Continue reading with a
two-week free trial.